CYPH Bear Put Spread Strategy
CYPH (Cypherpunk Technologies Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
CYPH (Cypherpunk Technologies Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $35.0M, a beta of -0.02 versus the broader market, a 52-week range of 0.232-3.7, average daily share volume of 4.8M, a public-listing history dating back to 2017, approximately 52 full-time employees. These structural characteristics shape how CYPH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.02 indicates CYPH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a bear put spread on CYPH?
A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.
Current CYPH snapshot
As of June 29, 2026, spot at $0.64, ATM IV 225.40%, IV rank 46.25%, expected move 64.62%. The bear put spread on CYPH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this bear put spread structure on CYPH specifically: CYPH IV at 225.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 64.62% (roughly $0.41 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CYPH expiries trade a higher absolute premium for lower per-day decay. Position sizing on CYPH should anchor to the underlying notional of $0.64 per share and to the trader's directional view on CYPH stock.
CYPH bear put spread setup
The CYPH bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CYPH near $0.64, the first option leg uses a $0.64 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CYPH chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CYPH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $0.64 | N/A |
| Sell 1 | Put | $0.61 | N/A |
CYPH bear put spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.
CYPH bear put spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bear put spread on CYPH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bear put spread on CYPH
Bear put spreads on CYPH reduce the cost of a bearish CYPH stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
CYPH thesis for this bear put spread
The market-implied 1-standard-deviation range for CYPH extends from approximately $0.23 on the downside to $1.05 on the upside. A CYPH bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on CYPH, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current CYPH IV rank near 46.25% is mid-range against its 1-year distribution, so the IV signal is neutral; the bear put spread thesis on CYPH should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CYPH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CYPH-specific events.
CYPH bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CYPH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CYPH alongside the broader basket even when CYPH-specific fundamentals are unchanged. Long-premium structures like a bear put spread on CYPH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CYPH chain quotes before placing a trade.
Frequently asked questions
- What is a bear put spread on CYPH?
- A bear put spread on CYPH is the bear put spread strategy applied to CYPH (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With CYPH stock trading near $0.64, the strikes shown on this page are snapped to the nearest listed CYPH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CYPH bear put spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the CYPH bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 225.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CYPH bear put spread?
- The breakeven for the CYPH bear put spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CYPH market-implied 1-standard-deviation expected move is approximately 64.62%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bear put spread on CYPH?
- Bear put spreads on CYPH reduce the cost of a bearish CYPH stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
- How does current CYPH implied volatility affect this bear put spread?
- CYPH ATM IV is at 225.40% with IV rank near 46.25%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.